Through the layers: how macrophages drive atherosclerosis across the vessel wall
Leah I. Susser, Katey J. Rayner
Leah I. Susser, Katey J. Rayner
Published May 2, 2022
Citation Information: J Clin Invest. 2022;132(9):e157011. https://doi.org/10.1172/JCI157011.
View: Text | PDF
Review Article has an altmetric score of 22

Through the layers: how macrophages drive atherosclerosis across the vessel wall

Abstract

Cardiovascular disease (CVD) accounts for almost half of all deaths related to non-communicable disease worldwide, making it the single largest global cause of mortality. Although the risk factors for coronary artery disease — the most common cause of CVD — are well known and include hypertension, high cholesterol, age, and genetics, CVDs are now recognized as chronic inflammatory conditions. Arterial blockages, known as atherosclerosis, develop due to excess cholesterol accumulating within the arterial wall, creating a perpetually inflammatory state. The normally quiescent intimal layer of the vessel wall becomes laden with inflammatory cells, which alters the surrounding endothelial, smooth muscle, and extracellular matrix components to propagate disease. Macrophages, which can be either tissue resident or monocyte derived, are a key player in atherosclerotic disease progression and regression, and the understanding of their functions and origins continues to evolve with the use of deep phenotyping methodologies. This Review outlines how macrophages interact with each layer of the developing atherosclerotic plaque and discusses new concepts that are challenging our previous views on how macrophages function and our evolving understanding of the contribution of macrophages to disease.

Authors

Leah I. Susser, Katey J. Rayner

×

Figure 1

Overview of macrophage function through the stages of atherosclerosis.

Options: View larger image (or click on image) Download as PowerPoint
Overview of macrophage function through the stages of atherosclerosis. I...
In the early stages of atherosclerosis, when cholesterol is abundant in the intima, MDMs are recruited via endothelial interactions and differentiation and, together with TRMs, engulf excess lipids to become foam cells. Certain macrophages adopt a proinflammatory M1-like phenotype that promotes inflammation and the formation of a necrotic core. During disease progression, endothelial cells can undergo EndoMT, and SMCs dedifferentiate into macrophage-like SMCs to become foam cells, all of which contribute to the growing plaque. To accommodate the growth in plaque size, ECM remodeling occurs through MMPs and, if the ECM is reduced and the SMC fibrous cap thins, plaques are prone to rupture. During disease regression and if cholesterol metabolism and efflux are efficient, macrophages take on a pro-resolving M2-like phenotype. An increase in M2-like macrophages alongside SPMs promotes inflammation resolution and plaque regression.